Lewis Joel
Galectin Therapeutics Inc. · President and CEO
Lewis Joel is listed in filings as President and CEO at Galectin Therapeutics Inc.. This profile follows SEC Form 4 activity through Jan 22, 2026, including sale activity. Recent filings connect the profile to Galectin Therapeutics Inc. (GALT). The current snapshot covers public activity from Dec 26, 2024 to Jan 22, 2026. Reported amounts are shown as $49.6K to $88.6K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $50k56k shares | SellDec 23, 2024 | $0.8859 | $4.18 | |
| $89k14k shares | SellSep 12, 2025 | $6.36 | $4.18 | |
| $7.8k1.3k shares | SellNov 3, 2025 | $6.01 | $4.18 | |
| $88k14.4k shares | SellNov 4, 2025 | $6.07 | $4.18 | |
| $1.2k200 shares | SellNov 5, 2025 | $6.00 | $4.18 | |
| $11k1.9k shares | SellNov 10, 2025 | $6.03 | $4.18 | |
| $95k15.7k shares | SellNov 17, 2025 | $6.04 | $4.18 | |
| $42k6.8k shares | SellNov 18, 2025 | $6.15 | $4.18 | |
| $55k7.8k shares | SellDec 17, 2025 | $7.06 | $4.18 | |
| $108k27.7k shares | SellJan 5, 2026 | $3.91 | $4.18 | |
| $78k18.6k shares | SellJan 2, 2026 | $4.20 | $4.18 |